Financing ·
Glucotrack, Inc. entered into Amendment No. 1 to its Common Stock Purchase Agreement with White Lion Capital, LLC on…
GCTKGlucotrack, Inc.
Glucotrack, Inc. entered into Amendment No. 1 to its Common Stock Purchase Agreement with White Lion Capital, LLC on August 7, 2026. The amendment modifies the commitment fee structure for 2,505,513 shares of common stock to be issued upon the effectiveness of a resale registration statement. If the Commitment Fee Price is less than the Minimum Price, Glucotrack must pay White Lion Capital a True-Up Amount equal to $1,000,000 minus the product of 2,505,513 shares and the Commitment Fee Price within 120 days. This equity issuance is exempt from registration under Section 4(a)(2) and Regulation D. Glucotrack operates in the healthcare technology industry, developing continuous glucose monitoring systems.